A pancreatic cancer drug is set to transform treatment
An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The drug, called daraxonrasib, has already been fast-tracked for […]